Want to join the conversation?
$VRX said it is pleased with the successful outcome of the Brodalumab FDA panel on July 19, 2016 and looks forward to progressing with this important drug through the approval process. The company continues to improve its managed care position, and maintained key product access on the ESI and Caremark exclusion list.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?